Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO.
Saved in:
| Title: | Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO. |
|---|---|
| Authors: | Gibiansky E; QuantPharm LLC, MD, USA., Petry C; F. Hoffmann-La Roche Innovation Center Basel, Switzerland., Mercier F; F. Hoffmann-La Roche Innovation Center Basel, Switzerland., Günther A; F. Hoffmann-La Roche Innovation Center Basel, Switzerland., Herman A; Genentech, South San Francisco, CA, USA., Kappos L; University Hospital Basel, Basel, Switzerland., Hauser S; University of California, San Francisco, CA, USA., Yamamoto Y; F. Hoffmann-La Roche Innovation Center Basel, Switzerland., Wang Q; F. Hoffmann-La Roche Innovation Center Basel, Switzerland., Model F; F. Hoffmann-La Roche Innovation Center Basel, Switzerland., Kletzl H; F. Hoffmann-La Roche Innovation Center Basel, Switzerland. |
| Source: | British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Jun; Vol. 87 (6), pp. 2511-2520. Date of Electronic Publication: 2020 Dec 07. |
| Publication Type: | Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2125 |
|---|---|
| DOI: | 10.1111/bcp.14658 |
